FDA approves less-invasive heart defibrillator
Copyright 2012 Scripps Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Posted: 09/28/2012
WASHINGTON (AP) - The Food and Drug Administration says it has approved a first-of-a-kind heart-zapping implant from Boston Scientific that that does not directly touch the heart.
Implantable defibrillators use thin wires to send electrical signals that disrupt dangerous heart rhythms. Surgeons have traditionally connected the wires to the heart through a blood vessel in the upper chest.
The new device from Boston Scientific uses wires that sit just below the skin's surface and do not need to be threaded through the heart's blood vessels.
Natick, Mass.-based Boston Scientific Corp. acquired the device through a $150 million buyout of San Clemente, Calif.-based Cameron Health. Under the terms of the deal, Boston Scientific will pay an additional $150 million for FDA approval, plus up to $1 billion in payments based on future sales figures.
Copyright 2012 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
PRINT
Top Science Tech News
-
Honeybees trained to find land mines
Mirjana Filipovic is still haunted by the land mine blast that killed her boyfriend and blew off her left leg while on a fishing trip nearly a decade ago. It happened in a field that was supposedly de-mined.
-
Mice, lizards return from month in space
-
2-mile-wide Asteroid to pass by Earth
-
Bernanke predicts gains from comp. tech
-
Facebook aims to be ad colossus
-
Report: Yahoo looks to acquire Tumblr
-
Atlanta woman gets 'programmable' hands
